Revised 09/2021
Dont miss out on the chance to advance your knowledge in MASH treatment and diagnostics
Patients without Neurofibromatosis type 1 (NF1) tend to have better outcomes than those with NF1-associated MPNST, as NF1-related tumors are more likely to be multifocal, high-grade, and resistant to therapy (Evans et al., 2021)
Why choose AYP Healthcare for Wegovy and Mounjaro treatments
According to co-author Karsten Eastman, a research associate in the university's Department of Chemistry and CEO and co-founder of Sethera Therapeutics, these structures are more stable, remain active longer, and can better interact with their biological targets
The choice between GLP-1 medications and non-GLP-1 medications depends on individual health considerations, potential side effects, and what is most likely to work for you, under the guidance of a healthcare provider